AEON Biopharma, Inc. (AEON) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $243K. Most recent filing: Aug. 21, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 21, 2026 filed Aug. 19, 2026 | LYNCH TIMOTHY P 10% Owner | +$243,455 | 1,150,000 | +21% | No | |
|
|
||||||
| June 22, 2026 filed June 17, 2026 | Thunen Shelley B Director | $0 | 222,684 | +618% | No | |
|
|
||||||
| June 22, 2026 filed June 17, 2026 | PALMISANO ROBERT J Director | $0 | 222,684 | +618% | No | |
|
|
||||||
| June 22, 2026 filed June 17, 2026 | Forth Marc Director | $0 | 222,684 | +30% | No | |
|
|
||||||
| June 22, 2026 filed June 17, 2026 | FISCHER JOST Director | $0 | 222,684 | +83% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free